Navigation Links
Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic

- The Hour-Long Special Narrated by Glenn Close Premieres November 18 at 9

AM ET/PT on Discovery Health -

NEW YORK, Nov. 12 /PRNewswire/ -- Nearly every society on earth is affected by diabetes -- one of the most pressing health crises facing humanity today. Currently, more than 246 million people worldwide are living with the disease, a number that is expected to explode to 380 million within 20 years. Despite recent advancements -- including new medications, monitoring devices and measurements -- the fight against diabetes continues to be an uphill battle. In an effort to raise awareness and uncover new clues for combating the disease, Discovery Health, with support from an unrestricted educational grant from Novo Nordisk, presents DIABETES: A GLOBAL EPIDEMIC -- the definitive look at how diabetes affects the global community.

Featuring narration from five-time Oscar nominee Glenn Close, DIABETES: A GLOBAL EPIDEMIC takes viewers across six continents to gain greater knowledge of the disease and how it affects different communities. In a television first, Discovery Health travels around the world to investigate diabetes' escalating human and economic toll across differing cultures and health care systems. The documentary's premiere comes on the heels of a historic milestone -- the first United Nations World Diabetes Day, which will be observed on November 14, 2007. With generous support from Novo Nordisk, the one-hour documentary will be presented commercial-free in the United States.

"This groundbreaking documentary shows diabetes for what it is: the silent epidemic of the 21st century, which doesn't discriminate between culture, continent or civilization," says Lise Kingo, executive vice president at Novo Nordisk. "The film also captures the care, professionalism and determination of all those who live with, treat and seek new treatments for diabetes around the world and who are working toward consigning diabetes to medical history."

DIABETES: A GLOBAL EPIDEMIC follows Francine Kaufman, MD, former American Diabetes Association president and head of the Center for Endocrinology, Diabetes and Metabolism at Children's Hospital Los Angeles, as she tours the world. Over a six-month period, Dr. Kaufman journeys from Los Angeles to Cape Town, South Africa; Chennai, India; Sao Paulo, Brazil; Melbourne and Perth, Australia; and Helsinki, Finland, in her quest to increase focus on the prevention, treatment and care of diabetes. In her travels, Dr. Kaufman meets with physicians and diabetes thought leaders to discuss the challenges of combating the disease, as well as their success stories of treatment and prevention. In addition, she spends time with diabetes patients of all ages who share their personal stories and offer a unique insight into the realities of living with the disease.

"During my travels, I realized that while diabetes is a worldwide issue, it often affects different cultures in different ways," said Kaufman. "It became clear to me that in order to effectively address the disease globally, we need to apply culturally sensitive solutions locally."

DIABETES: A GLOBAL EPIDEMIC gives audiences an in-depth understanding of the impact the westernization of the world has had on the incidence and prevalence of diabetes, and how differing cultures add unique dynamics to the problem at local levels.

We learn how South Africans don't want to be thin because of the stigma of AIDS. In India, when people become financially secure their eating increases- to be large in size symbolizes wealth and success. Australians talk about their country becoming a nation of sports watchers instead of sports players. All these factors are prompting leading experts to urgently join forces in the common goal of defeating this enemy, which can lead to blindness, heart disease and renal failure.

Medical professionals are eligible to receive CME credits for viewing DIABETES: A GLOBAL EPIDEMIC. More information is available at

About Novo Nordisk

Novo Nordisk is a healthcare company with an 84-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 25,000 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit; for United States information, visit

About Discovery Health Media Enterprises

Discovery Health Media Enterprises includes the Discovery Health and FitTV television networks and online assets including, as well as its Continuing Medical Education (CME) business and Discovery's first stand-alone VOD service, Discovery Health On-Call. Discovery Health Media Enterprises is part of Discovery Communications, the number-one nonfiction media company reaching more than 1.5 billion cumulative subscribers in over 170 countries. Discovery's 100-plus worldwide networks are led by Discovery Channel, TLC, Animal Planet, The Science Channel, Discovery Health and HD Theater, with digital media properties including Discovery Communications is owned by Discovery Holding Co. (Nasdaq: DISCA, DISCB), Advance/Newhouse Communications and John S. Hendricks, Discovery's founder and chairman. For more information please visit

SOURCE Discovery Health
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Discovery of sugar sensor in intestine could benefit diabetes
2. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
3. Stem cell research produces a key discovery for Fragile X Syndrome
4. Welch Foundation gives $1.6 million for drug discovery research
5. New discovery leaves blood-doping athletes scratching their heads
6. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
7. New discovery leaves blood-doping athletes scratching their heads
8. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
9. Discovery supports theory of Alzheimers disease as form of diabetes
10. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
11. New discovery may improve treatment of one of the worlds leading causes of blindness
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan ... a franchise owner, Somu now offers travelers, value and care based Travel Services, ... cruise sales, as well as, cabin upgrades and special amenities such as, shore ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes ... titles work with any font, giving users limitless opportunities to stylize and create ...
(Date:11/25/2015)... ... , ... The holiday season is jam-packed with family dinners, ... attendees is of the utmost importance. Whether you are cooking at home for ... a try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... European Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, ... (UNON) for the opening of the 5th African Network for Drugs and Diagnostics ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Dental professionals ... in Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring ... year in Cleveland, OH. , As the co-founders of Advanced Implant Mentoring (AIM), ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
(Date:11/25/2015)...  ARKRAY USA , Inc., a ... demonstrating the accuracy of its blood glucose meter systems. ... Diabetes and Cardiovascular Disease in Los Angeles ... ® 01 meter and the Assure ® ... to accurately measure glucose levels in blood is essential ...
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
Breaking Medicine Technology: